Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients/Experiment 1/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/20

Curator: Joiejoie

Revision editor(s): Joiejoie

Source: Figure S2D

Description: This figure highlights the microbial taxa dynamics associated with treatment response, emphasizing the potential role of specific gut microbiota in influencing clinical outcomes during anti-PD-1 therapy.

Abundance in Group 1: decreased abundance in complete responders (CR)

NCBI	Quality Control	Links
Clostridia_unclassified_SGB6369Clostridia_unclassified_SGB6369
Clostridia_unclassified_SGB14951Clostridia_unclassified_SGB14951
Clostridia_unclassified_SGB6293Clostridia_unclassified_SGB6293
Anaerostipes__caccaeAnaerostipes__caccae
Clostridiales_bacterium_S5_A14aClostridiales_bacterium_S5_A14a
p_Firmicutes_SGB47515p_Firmicutes_SGB47515
f_Bacteroidales_unclassified_SGB2173f_Bacteroidales_unclassified_SGB2173
Clostridiales_bacterium_BX7Clostridiales_bacterium_BX7
Carnobacterium_maltaromaticumCarnobacterium_maltaromaticum
Evtepia_gabavorousEvtepia_gabavorous
Eubacterium_maltosivoransEubacterium_maltosivorans
Clostridium_SGB6179Clostridium_SGB6179
Aggregatibacter_sp_oral_taxon_458Aggregatibacter_sp_oral_taxon_458
Candidatus_Cryptoclostridium_obscurumCandidatus_Cryptoclostridium_obscurum

Revision editor(s): Joiejoie